A r t i c l e s a suboptimal microenvironment, which helps them to invade and migrate without losing their stemness.
Self-renewal is a unique feature of all stem cells whereby they create identical daughter stem cells without differentiating into other cell types 1 . To maintain stemness, normal somatic stem cells need to be in a suitable environment, namely a niche, that provides proper cues to instruct them to self-renew and prevent them from differentiating [2] [3] [4] [5] . Niches for CSCs have been characterized in multiple different cancers, and they were shown to often resemble the structures and/or signals of niches for the tissues from which the CSCs originated [6] [7] [8] [9] . However, left unanswered is how CSCs still manage to maintain their stemness when they invade and migrate from their niches to other areas where optimal niches are less likely to be available 10 .
Glioblastoma (GBM; grade IV glioma) is the most common and lethal type of primary brain tumor in adults, with over 10,000 cases diagnosed annually in the United States 11, 12 . Evidence is emerging that a population of glioblastoma cells called GSCs possesses an inexhaustible ability to self-renew and produce intracranial tumors that retain the features of original tumors [13] [14] [15] . Several studies have shown that GSC niches are hypoxic and perivascular, resembling NSC niches such as the SVZ 6, 7 . However, niche-dependent maintenance of stemness fails to explain how GSC stemness is maintained when GSCs invade and migrate to new territories. Glioblastoma is a highly invasive disease [16] [17] [18] , and the ability of glioblastoma cells to use distinct anatomical structures to invade and migrate raises the question of how invading GSCs maintain their stemness when they face various compositions of matrix components in their environment. Therefore, we hypothesize that GSCs must acquire the ability to maintain stemness independently of their niches during invasion and migration. In this study, we used premalignant NSCs (PM-NSCs) with deletion of major tumor suppressors and the SVZ as a model system to study the interaction between GSCs and their niches.
To look for genetic alterations that could help PM-NSCs and GSCs maintain stemness outside of their niches, we previously screened a series of candidate genes and identified five tumor suppressors potentially affecting GSC stemness, one of which was QKI 19 . QKI encodes QKI, a STAR-family RNA-binding protein that is involved in various aspects of RNA homeostasis: RNA stability, splicing, translation, microRNA (miRNA) processing, and circular RNA biogenesis [20] [21] [22] [23] . Here we show that knockout of Qk decreases proliferation of Pten −/− ; Trp53 −/− PM-NSCs in niches but helps maintain their self-renewal outside niches in Nes-CreER T2 ; Qk L/L ; Pten L/L ; Trp53 L/L mice. This unique model system allowed us to discover a new underlying mechanism whereby GSCs maintain their high self-renewal capacity in Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation Fig. 1f) . To determine the impact of Qk deletion on NSC stemness, we first measured the number of NSCs in the SVZs of Nes-CreER T2 ; Qk +/+ and Nes-CreER T2 ; Qk L/L mice with a long-term 5-bromo-2′-deoxyuridine (LT-BrdU) labeling assay 2, 3 . We labeled all dividing cells from postnatal day (P) 1 Nes-CreER T2 ; Qk +/+ and Nes-CreER T2 ; Qk L/L mice (treated with tamoxifen at P0.5) with BrdU ( Supplementary  Fig. 2a ) and waited for 10 d to determine the number of long-term BrdU-retaining cells in SVZs. Double staining for LT-BrdU and Gfap (an NSC marker in the SVZ) was used to specifically examine NSCs. We found that Qk-null SVZs exhibited significantly higher numbers of LT-BrdU + Gfap + double-positive cells than SVZs with wild-type Qk (7% versus 2.5%, respectively; P = 0.01) (Fig. 1b,d) . Consistently, the Qk-null SVZs also contained significantly more nestin + Gfap + NSCs than SVZs with wild-type Qk (8.5% versus 3.3%, respectively; P = 0.01) (Fig. 1c,d) .
To determine whether the increase in NSC numbers in the SVZ by Qk deletion was associated with enhanced proliferation rate or enhanced self-renewal capacity, we first checked how Qk deletion would affect the proliferation rate of NSCs. A short-term BrdU incorporation assay showed that Qk deletion decreased the proliferation rate of NSCs in vitro (P = 0.01) (Fig. 1e) , consistent with the observation that Qk-null SVZs contained more Id1 + Gfap + quiescent NSCs than SVZs with wild-type Qk (P = 0.03) (Supplementary Fig. 2b ). The decreased proliferation rate of NSCs resulting from Qk deletion was not due to enhancement of cell death, as there was no difference in the apoptosis rate between NSCs with wild-type Qk and those null for Qk, either in vivo or in vitro (Supplementary Fig. 2c ).
To determine whether Qk deletion could enhance the self-renewal capability of NSCs, we first surveyed the sphere-forming ability of single cells, showing that Qk-null NSCs had a significantly higher capability of forming single-cell-derived neurospheres (P = 0.02 and P < 0.0001 with high and low concentrations of epidermal growth factor (Egf) and fibroblast growth factor (Fgf), respectively) ( Fig. 1f) , which were subsequently subjected to differentiation medium to determine their multipotency. This single-cell-based assay showed that one in 25 Qk-null NSCs could form secondary spheres when cultured with low concentrations of Egf and Fgf, as compared with one in 86 NSCs with wild-type Qk (passage 5; P < 0.0001), indicating that Qk deletion significantly enhances the self-renewal capacity of NSCs. Immunoblotting showed that Qk deletion also enhanced the levels of various self-renewal markers, including Sox2, Id1, Blbp, and Wnt signaling component Axin1 (Fig. 1g) . In addition, most NSCs with wild-type Qk showed a flattened cell morphology at late passages (for example, passage 25), indicating loss of stemness features, whereas at the same passages most Qk-null NSCs still maintained their spherical morphology (Supplementary Fig. 2d) .
Furthermore, we reasoned that, if self-renewal were enhanced, the differentiation of NSCs would also be repressed by Qk deletion. Immunofluorescent co-staining for lineage markers and GFP showed that the differentiation of adult NSCs into neurons (indicated by NeuN staining), astrocytes (indicated by Gfap staining), and oligodendrocytes (indicated by Olig2 staining) in the olfactory bulbs of P40 Nes-CreER T2 ; Qk L/L mice was significantly compromised by Qk deletion (P < 0.0001 for all; Fig. 1h) . Consistently, differentiation of embryonic and neonatal NSCs was also compromised by Qk deletion in Nes-CreER T2 ; Qk L/L mice that were injected with tamoxifen at embryonic day (E) 9.5 and P2, as shown by lineage marker staining (Mbp and Olig2 for oligodendrocytes, Tuj1 for neurons, and Gfap for astrocytes; P < 0.0003 for all) ( Supplementary Fig. 2e-h) . Collectively, these data suggest that, although Qk deletion directs NSCs toward a more quiescent state, it enhances NSC self-renewal capacity and blocks NSC differentiation.
Deletion of Qk maintains the stemness of Pten −/− ; Trp53 −/− PM-NSCs outside SVZs
Numerous studies have shown that NSCs in the SVZ are one of the possible cells of origin for malignant gliomas [26] [27] [28] . To investigate how Qk deletion would affect the interaction between PM-NSCs and their niches in vivo during gliomagenesis, we crossed the mTmG reporter allele 24 
cohorts to trace the fates of PP and QPP PM-NSCs with GFP labeling (Fig. 2a) . P38 SVZs from Nes-CreER T2 PP mTmG mice injected with tamoxifen at P8 were significantly enlarged relative to those from Nes-CreER T2 mTmG mice (P < 0.0001) (Fig. 2b,c and Supplementary  Fig. 3a) , indicating that deletion of Pten and Trp53 can lead to significant expansion of NSCs in their niches. However, PP PM-NSCs lost their stemness (as indicated by loss of staining for the stem cell marker Sox2 and the proliferating cell marker Ki67) (Supplementary Fig. 3a ) when they migrated beyond their niches (for example, to the thalamus and hypothalamus), fully differentiating into oligodendrocytes (Olig2 + GFP + and Mbp + GFP + ), neurons (NeuN + GFP + ), and astrocytes (S100β + GFP + ) with morphologies identical to those of wild-type cells (Supplementary Fig. 3b) . Further supporting the dependency of PP PM-NSCs on their microenvironment, we found that PP PMNSCs could grow and maintain their stemness only when they were orthotopically injected into the lateral ventricle but not the cortex (Supplementary Fig. 4a ). PP PM-NSCs that were injected into the cortex lost their stemness, as evidenced by higher levels of the differentiation marker Numb and lower levels of the Egfr and Fgfr receptors, which are essential for maintaining stemness, in comparison with PP PM-NSCs injected into the lateral ventricle ( Supplementary  Fig. 4b-d) . Because no gliomas formed in Nes-CreER T2 PP mTmG mice for up to 12 months after tamoxifen injection (Fig. 2d) , we concluded that, although deletion of Pten and Trp53 can promote the expansion of NSCs within their niches, it is insufficient to maintain NSC stemness beyond these niches, thereby preventing NSCs from developing into fully malignant gliomas. In contrast, 4.5% and 5.8% of GFP + cells found outside the SVZ (for example, in the thalamus or hypothalamus) of Nes-CreER T2 QPP mTmG mice were positive for Ki67 and Sox2, respectively (P < 0.0001) (Fig. 3a) . Similar observations were made in other regions of the brain, including the striatum and cortex (data not shown). Of the Ki67 + GFP + proliferating cells, 70% were Sox2 + stem cells (Supplementary Fig. 4e ). These data suggest that, unlike PP PM-NSCs, QPP PM-NSCs can still maintain their stemness outside the SVZ.
Because we showed that Qk deletion decreased NSC proliferation rate, enhanced NSC self-renewal capacity, and blocked NSC differentiation ( Fig. 1 and Supplementary Fig. 2) , we wanted to determine whether Qk deletion could have similar effects on PM-NSCs. BrdU incorporation assays showed that Qk deletion decreased the proliferation rate of PM-NSCs in vitro (P < 0.01) (Fig. 3b) . Consistently, 30 d after tamoxifen injection, the SVZs of Nes-CreER T2 QPP mTmG mice contained fewer Ki67 + GFP + proliferating cells than the SVZs of Nes-CreER T2 PP mTmG mice (P < 0.0001) (Fig. 3c) . To determine whether Qk deletion could enhance the self-renewal capability of PM-NSCs, we surveyed the sphere-forming ability of single cells, showing that Qk-null PM-NSCs had significantly greater capability to form single-cell-derived neurospheres (P = 0.02 and P < 0.0001 A r t i c l e s for low and high concentrations of Egf and Fgf, respectively) (Fig. 3d) . Consistent with the observation that Qk deletion reduced the differentiation capacity of NSCs, QPP PM-NSCs in the thalamus and hypothalamus of P38 mice also exhibited compromised differentiation in comparison with PP PM-NSCs in the same location (P < 0.0001 for all) (Fig. 3e,f and Supplementary Fig. 4f) . Collectively, these data show that, similar to NSCs, PM-NSCs with Qki loss have enhanced self-renewal capacity and a reduced tendency toward differentiation.
Deletion of Qk on a Pten −/− ; Trp53 −/− background promotes gliomagenesis Supporting the essential role of maintaining PM-NSC stemness outside of NSC niches in gliomagenesis, 92% of the Nes-CreER T2 QPP mice eventually developed gliomas, with a median survival time of 105 d (Fig. 2d) ; 44% of the gliomas were macroscopically evident at the cortex (Fig. 4a,b) , and the rest occurred in the parenchyma. Immunohistochemistry, immunoblotting, and PCR confirmed that most tumor cells did not express Qki, Pten, or p53, indicating that all three tumor suppressors need to be deleted to permit gliomagenesis ( Supplementary Fig. 4g-j) . These gliomas were all characterized as grade IV (glioblastoma) because they exhibited typical human glioblastoma features, including an invasive leading edge (Fig. 4c) , pseudopalisading necrosis (Fig. 4d) , hypervascularity (Fig. 4e) , microvascular proliferation (Fig. 4f) , perineuronal satellitosis ( Fig. 4g) , positive S100β and Gfap staining (Fig. 4h,i) , a high proliferative index (Ki67) (Fig. 4j) , positive staining for stem cell markers (for example, Notch1 and nestin) ( Supplementary Fig. 5a,b) , and high rates of infiltration by Iba1 + microglia/macrophages (Fig. 4k) . They also showed high intra-and intertumoral heterogeneity, manifesting as morphologically different cell types or growth patterns within the same tumors ( Fig. 4l) and among different tumors ( Supplementary Fig. 5c ). Glioblastomas that developed in NesCreER T2 QPP mice represented all four subtypes, including 37.5% proneural, 6% neural, 31% classical, and 25% mesenchymal, on the basis of transcriptomic profiling 29 (n = 16) (Fig. 4m) , demonstrating the plasticity of NSC-derived glioblastoma. Thus, maintaining the stemness of PM-NSCs outside their niches by Qk deletion can promote development of glioblastoma that recapitulates features of human glioblastoma. As with Nes-CreER T2 QPP mTmG mice injected with tamoxifen at P8, Nes-CreER T2 QPP mTmG mice injected with tamoxifen at P30 also developed glioblastoma, with a penetrance of 73% and a median survival time of 200 d, suggesting that, like NSCs from early postnatal mice, NSCs from adult mice with deletion of Qk, Pten, and Trp53 also have great potential to develop into glioblastoma ( Supplementary Fig. 5d ). Moreover, supporting the idea that Qki can function as a tumor suppressor under different genetic backgrounds, we found that Glioma-free survival (100%) A r t i c l e s Supplementary Fig. 5e ).
RNA-binding protein Qki regulates endolysosomes
To understand how Qk deletion can enhance the self-renewal capacity of Pten −/− ; Trp53 −/− PM-NSCs, especially outside their niches, we sought to identify the genes that are changed by Qk deletion at the total mRNA level, the alternative splicing level, and the protein level because Qki has been shown to regulate RNA stability, alternative splicing, and translation 23 . We first performed transcriptomic profiling with RNA-seq on NSCs with wild-type Qk and Qk-null NSCs as well as on PP and QPP PM-NSCs. We then integrated these two data sets and identified 388 overlapping genes (P < 0.01, fold change > 1.5) (Supplementary Table 1 ). Analyzing the same RNA-seq data set with SpliceSeq Analyzer also found that the alternative splicing of 217 genes was altered by Qk deletion in both NSCs and PM-NSCs (P < 0.05) (Supplementary Table 2 ). To identify genes changed by Qk deletion at the protein level, we performed stable isotope labeling by amino acid in cell culture (SILAC)-coupled mass spectrometry-based quantitative proteomics on PP and QPP PM-NSCs ( Supplementary Fig. 6a ).
We discovered that 290 proteins were upregulated (Supplementary Table 3 ) and 343 proteins were downregulated (Supplementary Table 4) in QPP PM-NSCs in comparison with PP PM-NSCs (fold change > 1.2).
To determine the direct targets of the Qki protein among the genes whose expression or products were changed by Qk deletion at different levels, we performed photoactivatable-ribonucleoside-enhanced cross-linking and immunoprecipitation (PAR-CLIP)-coupled RNA-seq analyses on PM-NSCs to identify Qki-associated RNAs, with known Qki-binding motif AYUAAY (where Y is C or U) 30 ( Fig. 5a) . 32 P labeling coupled with SDS-PAGE showed that this approach could specifically pull down Qki-associated RNAs (Fig. 5b) , which were subsequently characterized with Illumina RNA-seq and computational analyses. We then integrated the transcriptomic profiles, proteomic profiles, and PAR-CLIP data and found that 104 genes that changed at the mRNA level, 73 genes that changed at the splicing level, and 148 genes that changed at the protein level showed high confidence of being direct targets of Qki because the RNAs they encode also physically interacted with Qki protein (Supplementary Table 5 ). Pathway analysis on these Qki targets by Ingenuity Pathway Analysis (IPA) identified 15 pathways that were highly enriched (P < 0.001) (Supplementary Fig. 6b ). Twelve of these 15 pathways (80%) are involved in receptor signaling and trafficking, including cytoskeleton regulation, endocytosis, and lipid biosynthesis (which is critical for vesicle formation). In further breaking down which pathways QPP mTmG mice injected with tamoxifen at P8 (n = 6 mice/group; Student's t test). (d) Percentages of early-passage (passage 5) PP and QPP PM-NSCs that can form neurospheres from single cells cultured with either full-strength growth factors (20 ng/ml Egf + 10 ng/ml Fgf) or a 1:10 dilution of growth factors (2 ng/ml Egf + 1 ng/ml Fgf) (n = 6 cell lines/group; Student's t test, *P = 0.02, **P < 0.0001). (e,f) Representative immunofluorescence images and quantification of Olig2 + GFP (e) and NeuN + GFP (f) co-staining of the thalamus and hypothalamus in P38 Nes-CreER T2 PP mTmG and Nes-CreER T2 QPP mTmG mice injected with tamoxifen at P8 (n = 5 mice/group; Student's t test). Scale bars: 100 µm in a and c, and 50 µm in e and f. Error bars, s.d. All the experiments were replicated three times in the laboratory.
A r t i c l e s are upregulated or downregulated by Qk deletion, we found that 45% of the genes that were upregulated at the mRNA level and 18% of the genes that were upregulated at the protein level encode either receptors (especially G-protein-coupled receptors (GPCRs)) or proteins that are involved in delivering receptors to the cytoplasmic membranes (Fig. 5c,d and Supplementary Table 2 ). We also found that 39% of the genes that were downregulated by Qk deletion at the mRNA level and 40% of the genes that were downregulated at the protein level are involved in regulating endocytosis-mediated receptor degradation, including for multiple caveolin and clathrin subunits and various components of endosomes and lysosomes (Fig. 5c,d and Supplementary Table 2 ). Finally, we also discovered that 37% of the genes that were changed at the splicing level encode proteins that are involved in receptor trafficking (Supplementary Table 2 ). We found that Qk deletion did not affect the expression of the endolysosome biogenesis regulators Tfe3/Tfeb/Mitf, suggesting that Qki provides another level of regulation by regulating RNA homeostasis of endolysosome components. To verify the direct interaction of Qki and its substrates, we selected the top 15 Qki substrates in the endolysosomal pathway and were able to confirm enrichment of these RNAs in the Qki immunocomplex by PAR-CLIP analysis followed by qPCR (Fig. 5e) . 
A r t i c l e s

Qk deletion decreases endolysosome levels
The enrichment of endolysosome components among the Qki targets made us hypothesize that Qk deletion maintains the self-renewal of stem cells in suboptimal environments by downregulating endolysosomedependent degradation. Downregulation of endolysosome levels was confirmed by immunoblotting of key components such as endosome components Rab5 and Rab7 and lysosome components Lamp1 and Lamp2 ( Fig. 5f and Supplementary Fig. 7a ). Downregulation of endolysosome levels by Qk deletion was also confirmed by Lysotracker staining (Fig. 6a) as well as by double staining for Gfap and Lamp1 (Fig. 6b) and for LT-BrdU and Lamp1 (Supplementary Fig. 7b ) in SVZs in vivo. Furthermore, uptake of Alexa Fluor-labeled transferrin and low-pH-sensitive probe pHrodo Red EGF from the culture medium was greatly decreased Qk-null NSCs and PM-NSCs in comparison with NSCs and PM-NSCs with wild-type Qk (Fig. 6c and Supplementary Fig. 7c,d) , suggesting that Qk deletion greatly compromises the endocytosis of receptors. We also found that the mRNA levels of the endolysosomal components/regulators CLTC, RAB5A, RAB5B, RAB5C, RAB7, RAB28, LAMP1, LAMP2, SNX2, SNX3, and GPHN were all positively correlated with QKI mRNA levels in The Cancer Genome Atlas (TCGA) data set (Pearson correlation, P < 0.0001 for all; Fig. 6d and Supplementary Fig. 7e ), suggesting that downregulation of endolysosome levels by low QKI levels also occurs in human glioblastoma samples. Altogether, these data suggest that QKI positively regulates multiple components of the endolysosome-dependent degradation machinery through various RNA-regulating mechanisms.
Downregulation of receptor degradation enhances PM-NSC stemness
One of the main functions of niches is to provide various ligands for receptors that are essential for maintaining stem cell self-renewal 1 .
Because Qk deletion could enhance receptor-ligand activity by downregulating endolysosome-dependent receptor and ligand degradation, we hypothesized that this mechanism would help maintain NSC self-renewal when the concentrations of exogenous ligands were lower. Supporting the role of decreased endolysosome-dependent degradation in regulating stemness, we found that Lamp1 and Lamp2 levels in PM-NSCs were much lower than in differentiated PM-NSCs that were induced by low concentrations of Egf and Fgf (Fig. 7a) . In comparison with PP PM-NSCs, when cultured with low concentrations of Egf and Fgf, QPP PM-NSCs still expressed low levels of lysosomes, maintained high levels of stem cell markers (such as Sox2 and Axin1), and expressed low levels of differentiation markers, such as Gfap and S100β (Fig. 7a) . To determine whether low levels of endolysosomes have a causal role in determining stem cell state, we inhibited endolysosomal degradation by Lamp1 knockdown and discovered that it significantly enhanced the self-renewal of PP PM-NSCs, as indicated by enhanced serial sphere-forming ability, particularly with low concentrations of Egf and Fgf (P < 0.0001 for both assays) (Fig. 7b) . Reinforcing the function of endolysosomes in tumorigenesis, we discovered that knockdown of Lamp1 greatly promoted xenograft tumor growth of PP PM-NSCs, whereas control PP PM-NSCs did not form any tumors during the observation A r t i c l e s period (over 3 months; Supplementary Fig. 7f ). Supporting the idea that restoration of endolysosomes can reverse the low differentiation capability and high self-renewal ability caused by Qk deletion, we found that endolysosome biogenesis induced by ectopic Tfe3 in QPP PM-NSCs could significantly decrease the expression of the stemness marker Sox2 and serial sphere-forming ability, and could also increase the expression of the differentiation marker Gfap (Supplementary Fig. 7g) .
We next sought to check whether receptors that are known to be important for maintaining NSC self-renewal (such as Notch1, Frizzled, and receptor tyrosine kinases (RTKs)) 31, 32 can be enriched by downregulation of endolysosomes caused by Qk deletion. Immunofluorescent staining showed that the ventricular zones and SVZs of E14.5 Nes-CreER T2 ; Qk L/L embryos that were treated with tamoxifen at E9.5 expressed a significantly higher level of Notch1 than those of control Nes-CreER T2 ; Qk +/+ embryos (P < 0.0001) (Fig. 7c) . Consistently, immunoblotting also showed that both Notch1 and cleaved Notch1 (NICD) were greatly upregulated in Qk-null NSCs in comparison to NSCs with wild-type Qk in vitro (Fig. 7d) . Immunofluorescent staining also showed that membrane Frizzled levels were much higher in the SVZs of P12 Nes-CreER T2 ; Qk L/L mice that were treated with tamoxifen at P1 than they were in control Nes-CreER T2 ; 
A r t i c l e s
Qk +/+ mice (P < 0.0001) (Fig. 7e) . Immunoblotting showed that the autocrine Wnt ligands Wnt5a and Wnt5b were also upregulated in Qk-null NSCs in comparison to NSCs with wild-type Qk, and as a consequence of higher levels of Wnt receptors and ligands the levels of Wnt downstream target (activated β-catenin) were also upregulated in Qk-null NSCs (Fig. 7f) . Similar to NICD and Frizzled, the levels of 
Egfr protein in NSCs were also significantly upregulated by Qk deletion in vitro (Fig. 7d) . Finally, we found that transient expression of Qki in QPP PM-NSCs could rescue Lamp1 levels and downregulate Notch1 and Fgfr protein levels (Supplementary Fig. 8a ). Supporting the notion that receptors are enriched by Qk deletion through skewed degradation rather than transcription and/or translation, co-staining of ectopically expressed Egfr and Frizzled with Lamp1 showed that receptors undergoing endocytosis were greatly downregulated while receptors remaining on the cytoplasmic membranes were greatly upregulated in Qk-null PM-NSCs (P < 0.0001) (Fig. 7g-i) . Supporting the idea that decreased receptor degradation caused by low QKI levels also contributes to enhanced receptor levels and GSC populations in human glioblastoma, we found that positivity of QKI staining negatively correlated with positivity of FRIZZLED, NOTCH1, and EGFR as well as stem cell marker SOX2 staining in human glioblastoma tissue microarray (TMA) samples (χ 2 test, P < 0.0001 for all; Fig. 8a ). Reinforcing the notion that Qk deletion enhances self-renewal by downregulating endolysosome-dependent degradation of receptors, we found that pharmacological inhibition of Notch1, Wnt, and Egfr activities could diminish higher self-renewal capacity caused by Qk deletion (Fig. 8b and Supplementary Fig. 8b,c) . Finally, to evaluate whether QKI and endolysosome status can predict patient survival, we used immunohistochemistry to measure QKI protein levels and endolysosome levels (indicated by punctate LAMP1 staining) in human glioblastoma TMA samples with patient survival data (Supplementary Table 6 ). We found that over 63% and 50% of the cancer cells in half of the glioblastoma samples expressed QKI and endolysosome levels below the detection limit, respectively (Supplementary Fig. 8d-g ). Consistent with the importance of QKI and endolysosomes in human gliomagenesis, higher percentages of the QKI-low or endolysosome-low cells correlated significantly with poorer prognosis in human patients with glioblastoma (Fig. 8c) . Overall, the above data demonstrate that loss of QKI enables PMNSCs to maintain their self-renewal capacity when subjected to low concentrations of ligands (as found in suboptimal environments outside of niches) by downregulating endolysosome-mediated degradation of various receptors (NOTCH1, FRIZZLED, RTKs, etc.) that are critical for maintaining stemness.
DISCUSSION
The niche is a special environment where stem cells are maintained in an undifferentiated state and propagated through self-renewal 1 . As seen for somatic stem cells, numerous studies have identified niche structures for CSCs that are important for maintaining their selfrenewal and promoting tumorigenesis [6] [7] [8] [9] . However, these seemingly specialized CSC niches are absent when CSCs invade other areas or tissues by various routes and metastasize to distant organs via the circulation. This raises the question of how CSCs maintain their 34 . Mutations of cancer-related genes that uncouple receptors from endocytosis-mediated downregulation have been found to have critical roles in tumorigenesis. One example is c-Cbl, an E3 ubiquitin ligase that conjugates ubiquitin onto receptors to poise them for endocytosis 35, 36 . Ying et al. 37 discovered that a novel tumor suppressor, Mig-6, recruits Egfr to endocytic vesicles and drives Egfr into lysosome-mediated degradation by binding to SNARE protein Stx8. In our study, we have established, to our knowledge, the first link between downregulation of endolysosomes and enhanced self-renewal of PMNSCs and GSCs, thus providing a new mechanism by which PM-NSCs and GSCs cope with suboptimal environments during gliomagenesis.
QKI has long been studied as a gene critical for oligodendrocyte differentiation and myelin formation 23, 38, 39 , and our results confirmed that Qki is required for oligodendrocyte differentiation in vivo. Qki has also been shown to be important for the development of smooth muscle, endothelial cells, and monocytes/macrophages 23 . In addition, we discovered that Qki is also highly expressed in NSCs and is a major regulator of self-renewal and differentiation. QKI has been shown to regulate various aspects of RNA homeostasis: RNA stability, splicing, translation, miRNA processing, and circular RNA biogenesis [20] [21] [22] [23] 39 . Here we found that Qki can regulate endocytosis by at least modulating RNA stability and splicing. It is likely that Qki also regulates endocytosis indirectly by affecting miRNA processing and circular RNA biogenesis.
Supporting the importance of the function of QKI as a tumor suppressor, a previous analysis of the TCGA database of glioblastoma defined QKI as the sole gene within the minimal common region of the 6q26 deletions (32% deletion rate and 1.7% mutation rate) 40 . Furthermore, QKI downregulation by methylation of the QKI locus (chromosome 6, base 163,755,107) was also reported in 50 of 250 (20%) glioblastoma samples 20 . In angiocentric glioma, nearly 90% of tumors have MYB-QKI translocation, which results in disruption of QKI function 41, 42 . Other than in gliomas, QKI has been shown to be a tumor suppressor in other malignancies, including gastric 43 , breast 44 , colon 45 , prostate 46 , and oral 47 cancers.
In conclusion, the downregulation of endolysosome-dependent degradation of receptor-ligand complexes caused by Qk deletion is a new mechanism for PM-NSCs and GSCs to maintain stemness in suboptimal environments outside their niches. This study may lead to cancer therapeutic opportunities targeting the mechanisms involved in maintaining CSC stemness, such as receptor trafficking, endocytosis, and autophagy/lysosome-dependent protein degradation.
METhODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. to four times. For immunocytochemical assays, glass coverslips were coated with 2 µg/ml fibronectin (R&D Systems) in PBS overnight, and cells were seeded on the coverslips. For induction of differentiation, cells were cultured with DMEM/F12 (Thermo Fisher Scientific) containing either 2% FBS or 100 ng/ml IGF-1, 60 ng/ml T3 (Thermo Fisher Scientific), and 50 units/ml penicillin G and 50 µg/ml streptomycin. For self-renewal/proliferation assays, NSCs and PM-NSCs were dissociated and seeded in 96-well plates as single cells. The formation of neurospheres was monitored every day. All neurospheres bigger than 50 µm in diameter were considered as true neurospheres, and the sizes of these spheres were monitored and measured.
AUTHoR CoNTRIBUTIoNS
Long-term BrdU incorporation assays in vivo. Given that the NSC population in SVZs is relatively quiescent, using the long-term BrdU labeling assay will capture true NSCs while transit-amplifying progenitor cells (TAPs) will continue to proliferate and dilute the BrdU. We injected P1 Nes-CreER T2 ; Qk +/+ and Nes-CreER T2 ; Qk L/L mice with tamoxifen followed by BrdU injection for 1 d (with an interval of 6 h) and waited for 1 d and for 10 d to check short-term and long-term BrdU retention, respectively. Immunofluorescence staining of BrdU at 1 d after BrdU injection showed that most of proliferating cells in SVZs were labeled. Because at this stage cells in SVZs grow very rapidly, at 10 d, most of the BrdU staining had been diluted out, with only relatively quiescent NSCs still retaining BrdU staining.
Endocytosis and cell fluorescence measurement. The endocytosis assay was performed using pHrodo Red EGF conjugates (Thermo Fisher Scientific) according to the manufacturer's instructions. Cell fluorescence was measured using ImageJ. Briefly, cells on fibronectin-coated 96-well flat-bottom plates were kept on ice for 10 min, washed with cold Live Cell Imaging Solution (LCIS, Thermo Fisher Scientific), and treated with 2 µg/ml EGF conjugate for 5 min. Cells were then washed with LCIS, and images were obtained using a fluorescence microscope (Leica DMi8). The images were analyzed using ImageJ to measure corrected total cell fluorescence.
RNA isolation. RNA was isolated from mouse brains, tumors, NSCs, PM-NSCs, and GSCs using the RNeasy mini kit (Qiagen), according to the manufacturer's instructions.
Protein isolation. Cells were collected, washed with PBS, lysed in RIPA buffer (150 mM NaCl, 50 mM Tris, pH 8.0, 1.0% Igepal CA-630, 0.5% sodium deoxycholate, 0.1% SDS, Sigma-Aldrich) with a protease inhibitor cocktail tablet (cOmplete mini, Roche Diagnostics), Phosphatase Inhibitor Cocktail 2 (Sigma-Aldrich) and 1 µM DTT, and centrifuged at 10,000g at 4 °C for 15 min. The supernatant was used as the cell lysate in standard immunoblotting. Briefly, 20-50 µg of protein was subjected to SDS-PAGE on a 4-12% gradient polyacrylamide gel (NuPAGE, Thermo Fisher Scientific), transferred to a nitrocellulose membrane (Trans Blot Turbo, Bio-Rad), and incubated with the indicated primary antibodies followed by incubation with speciesappropriate HRP-conjugated secondary antibodies. Bound antibodies were visualized using SuperSignal enhanced chemiluminescence system (Thermo Fisher Scientific).
Subcutaneous and intracranial cell injections.
For subcutaneous injections, female nude mice (NCr, Taconic) aged 6-8 weeks were anesthetized, and 1 million control PP NSCs and Lamp1 knockdown PP NSCs were injected into each flank. Tumor volumes were calculated on the basis of ½ (length × width 2 ) of the tumor. For intracranial injections, female SCID mice (Taconic) aged 6-8 weeks were anesthetized and placed into a stereotactic apparatus equipped with a z axis (Stoelting). A small hole was bored into the skull 0.5 mm anterior and 3.0 mm lateral to the bregma using a dental drill; 1 × 10 5 cells in NeuroCult were injected into the right lateral ventricle using a 10-µl Hamilton syringe with an unbeveled 30-gauge needle. The scalp was closed using a 9-mm Autoclip Applier. Animals were monitored for the development of neurological deficits every other day. All manipulations were performed with IACUC approval.
RNA-seq and alternative splicing analyses. Total RNA sequencing was performed by the Illumina Next-Generation Sequencing Service at the Sequencing and Microarray Facility of MD Anderson. RNA sequence data analyses were performed with the typical RNA data analysis pipeline. We used the TopHat program to align RNA sequence data against the mm10 version of the mouse genome, allowing two mismatches. After applying the easyRNA R package to extract raw count tables based on the aligned BAM files, we used edgR to perform normalization and differential gene expression analysis. Alternative splicing analyses were performed on the SpliceSeq platform. The detailed protocol is listed at http://bioinformatics.mdanderson.org/main/SpliceSeqV2:Methods.
SILAC quantification. Pairs of Qk-wild-type and Qk-null PM-NSCs were cultured with DMEM:F12 (1:1) medium minus l-Lysine and L-Arginine (Pierce), supplemented with B27, Egf and Fgf, and with regular l-arginine-HCL and l-leucine-HCL, or with heavy l-arginine-HCl (13C6) and l-leucine-HCl (13C6), for more than six passages. Cells were then lysed with RIPA buffer and mixed 1:1, accurately. The mixed lysates were fractionated by SDS-PAGE until markers had migrated 5 cm toward the anode. The gel was then stained with Coomassie blue and cut into five 1-cm pieces. Each piece was further cut into 1-mm cubes, which were combined in one Eppendorf tube and sent to the Proteomics Core Facility at The University of Texas Southwestern Medical School for quantification.
PAR-CLIP.
The PAR-CLIP assay followed procedures described previously 30 . In brief, Qk −/− ; Pten −/− ; Trp53 −/− PM-NSCs were transduced with HA-Qki5. Cells were cultured in 0.5 mM 4-thiouridine for 14 h followed by cross-linking with 0.6 J/cm 2 (around 2 min) of 365-nm UV light in a Stratalinker 2400 (Stratagene). Cross-linked cells were lysed in NP-40 buffer with a Dounce homogenizer and filtered through a 0.2-µm syringe filter. The cell lysate was treated with RNase T (1 U/µl) at 22 °C. Qki-RNA complexes were immunoprecipitated with antibody to HA. Beads were washed and treated with RNase T1 (100 units/µl) for 15 min at 22 °C and then dephosphorylated using intestinal alkaline phosphatase (0.5 units/µl, New England BioLabs) for 10 min at 37 °C. RNA on the beads was labeled with [γ-32 P]ATP to a final concentration of 0.5 µCi/µl and T4 PNK (New England BioLabs) was added to 1 unit/µl in one original bead volume for 30 min at 37 °C. Qki-RNA complexes on the beads were then denatured for 5 min in a heat block at 95 °C and separated on a Novex Bis-Tris 4-12% (Invitrogen) precast polyacrylamide gel. Qki-RNA complexes were transferred to a nitrocellulose membrane, and bands that corresponded to the expected size (40-50 kDa) were cut out. The bands were treated with proteinase K for 30 min at 55 °C. RNA was recovered by acidic phenol:chloroform:IAA extraction (25:24:1, pH 4.0), followed by a chloroform extraction, and sent out for Illumina RNA-seq. qPCR primers for verifying Qki targets are listed in Supplementary Table 7. Electron microscopy. Cells were fixed with a solution containing 3% glutaraldehyde plus 2% paraformaldehyde in 0.1 M cacodylate buffer, pH 7.3, overnight. Samples were processed by K. Dunner Jr. at the High Resolution Electron Microscopy Facility at MD Anderson.
Immunofluorescence and immunohistochemistry analyses on human tissue microarrays. The TMAs consisted of resected glioma tissues from glioblastoma (n = 130) and normal brain (cortex; n = 19). The human tumor sample collection has been described previously 49 . In brief, tumor tissues were resected from patients and collected in accordance with the Institutional Review Board of MD Anderson. For TMA construction, two 1-mm cores were obtained per tumor sample. The rationale for using a TMA was to facilitate an analysis of the largest number of tumor samples possible. The neuropathologists gathered the tissue sections from the archived paraffin blocks and confirmed each tumor's pathological type. For immunohistochemistry staining of QKI and immunofluorescence staining of QKI, EGFR, NOTCH1, FRIZZLED, and SOX2, procedures were as described in "Immunohistochemistry" and "Immunofluorescence. " To analyze co-staining of QKI with EGFR, NOTCH1, FRIZZLED, and SOX2, 45 individual samples were used. Ten randomly picked independent fields of 10 4 µm 2 were selected for each sample, and ten individual cells were picked for each field. For individual cells, if the staining was obviously higher than the background, they were labeled as "high"; otherwise, they were labeled as "low." Correlations between QKI staining and EGFR, NOTCH1, FRIZZLED, or SOX2 staining were determined with the χ 2 test. P < 0.0001 indicates that
